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Abstract
Direct cell-cell spread of Human Immunodeficiency Virus type-1 (HIV-1) at the virological synapse (VS) is an efficient mode of
dissemination between CD4
+ T cells but the mechanisms by which HIV-1 proteins are directed towards intercellular contacts
is unclear. We have used confocal microscopy and electron tomography coupled with functional virology and cell biology of
primary CD4
+ T cells from normal individuals and patients with Chediak-Higashi Syndrome and report that the HIV-1 VS
displays a regulated secretion phenotype that shares features with polarized secretion at the T cell immunological synapse
(IS). Cell-cell contact at the VS re-orientates the microtubule organizing center (MTOC) and organelles within the HIV-1-
infected T cell towards the engaged target T cell, concomitant with polarization of viral proteins. Directed secretion of
proteins at the T cell IS requires specialized organelles termed secretory lysosomes (SL) and we show that the HIV-1
envelope glycoprotein (Env) localizes with CTLA-4 and FasL in SL-related compartments and at the VS. Finally, CD4
+ T cells
that are disabled for regulated secretion are less able to support productive cell-to-cell HIV-1 spread. We propose that HIV-1
hijacks the regulated secretory pathway of CD4
+ T cells to enhance its dissemination.
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Introduction
Viral replication is a complex series of well-orchestrated events
culminating in the release of progeny virions from infected cells.
For efficient viral production, all components must be mobilized to
the site of assembly in a coordinated manner, achieved by enlisting
components of cellular transport pathways. It is becoming in-
creasingly clear that cell-to-cell spread is an important mechanism
of viral dissemination [1] and has a number of advantages for
viruses, including more rapid and efficient uptake by permissive
target cells. However, this process requires an exquisite level of
regulation to polarize virus assembly and release towards engaged
target cells at sites of cell-cell contact. Direct spread of Human
Immunodeficiency Virus type-1 (HIV-1) between CD4
+ T cells
takes place across a supramolecular structure called the ‘‘virolog-
ical synapse’’ (VS) [2]. Another mode of HIV-1 spread between
immune cells is via membrane nanotubes [3], although these
structures form less frequently than VS and so probably contribute
less to viral dissemination [3,4]. The VS was so named because of
structural and functional similarity to the immunological synapse
(IS) that evolves between an antigen presenting cell and a T cell
[5]. The VS is characterised by rapid, actin-mediated recruitment
of the HIV-1 entry receptors (CD4 and a chemokine receptor) and
adhesion molecules on the target cell, synchronous with polar-
ization of the HIV-1 envelope glycoprotein (Env), the Gag
polyprotein and integrins in the infected cell. Within the HIV-1
+
infected cell, Env and Gag polarization is actin- and tubulin-
dependent, and requires lipid raft integrity [6,7,8], implying that
viral proteins are actively recruited to the site of cell-cell contact.
Indeed, live cell imaging visualizing de novo virus assembly at the
VS has shown recruitment of Gag to sites of cell-cell contact [9].
By contrast, the pathway of Env trafficking in infected T cells and
the molecular mechanisms underlying active Env enrichment at
the VS remain poorly understood. Once at the VS, cell-to-cell
spread of HIV-1 is by polarized assembly and budding of virions
into the synaptic cleft and subsequent fusion with the target cell
plasma membrane either at the cell surface or from within an
endosomal compartment [9,10].
Polarized secretion at the IS has been well studied in CD8
+ T
cells and is directed by antigen-dependent reorientation of the
microtubule organizing center (MTOC) to sites of cell-cell contact,
and the regulated movement and release of SL towards the
engaged target cell [11]. By contrast, little is known about
regulated secretion in CD4
+ T cells [12,13]. MTOC polarization
at the IS occurs in CD4
+ T cells [14], and the surface expression of
membrane-associated proteins such as CTLA-4 (a negative
regulator of T cell activation) and FasL (a pro-apoptotic receptor)
is likely to be under the same strict temporal and spatial control
orchestrated by the regulated secretory pathway in response to
T cell receptor (TCR) stimulation in both lymphocyte types
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and interferon-c is also activated at the CD4
+ T cell IS, thereby
focusing the exocytosis of specific soluble proteins towards target
cells following cell-cell contact [21,22].
Directed egress of HIV-1 at the VS is reminiscent of polarized
secretion by T cells at the IS that is coordinated by the regulated
secretory pathway (reviewed in [11,12,13]). We therefore hypoth-
esized that HIV-1 may harness elements of this pathway to
orchestrate egress from CD4
+ T cells and promote cell-to-cell
spread. Here we confirm that CD4
+ T cells contain a com-
partment that is similar to SL in CD8
+ T cells and show that the T
cell regulated secretory pathway contributes to HIV-1 cell-to-cell
dissemination, providing the first evidence that lymphotropic
viruses can hijack regulated secretion to enhance pathogenesis.
Results
The HIV-1 VS has a regulated secretion phenotype
A characteristic feature of IS formation and regulated secretion
by T cells at sites of cell-cell contact is polarization of the micro-
tubule organizing center to the conjugate interface, aligning the
secretory apparatus of the T cell proximal to the contact site and
directing secretion towards the engaged target cell [14,23,24,
25,26,27,28]. To investigate whether similar polarization occurs at
the VS we performed immunofluorescence staining and confocal
microscopy and quantified MTOC localization in conjugates
between HIV-1-infected primary CD4
+ T cells and autologous
target T cells. MTOC polarization was examined in conjugates
that had evolved VS (identified by the enrichment of HIV-1
proteins in the infected T cell at the contact site) and was
compared to conjugates between infected and uninfected cells that
had not formed VS (i.e. did not show HIV-1 enrichment at the
contact site). In a manner analogous to the T cell IS, we observed
statistically significant polarization of the MTOC within HIV-1-
infected primary CD4
+ T cells towards engaged autologous target
T cells at the VS (Fig. 1a). Alignment of the MTOC in infected
cells proximal to the site of cell-cell contact occurred in 60%
610% of VS (n=31, p=0.004) compared to 24% 64% of
conjugates that were in contact but had not formed a VS (n=40).
Intracellular clusters of HIV-1 Env were observed near to the
polarized MTOC and close to the cell-cell interface (Fig. 1a),
although the necessity for methanol permeabilization for c-tubulin
labeling in T cells resulted in the loss of most surface Env signal.
On average the MTOC within the HIV-1 infected cell was located
1 mm from the plasma membrane at the VS (Fig. 1a) whereas
HIV-1 independent contacts between two uninfected T cells did
not induce polarization and the MTOC was on average 5 mm
from the cell-cell interface. Thus MTOC polarization at sites of
cell-cell contact correlates with VS assembly in HIV-1 infected T
cells.
The tubulin cytoskeleton is implicated in promoting cell-to-cell
dissemination of HIV-1 at the VS [7]. We therefore hypothesized
that by analogy with the IS, MTOC polarization might align viral
antigen-containing secretory organelles at the VS and organize the
microtubule network for efficient HIV-1 egress via directional
budding. In order to visualize cellular secretory components at the
VS in more detail we performed ultrastructural analysis by
electron microscopy (EM) and tomography. Fig. 1b shows an
example of a conjugate formed between an HIV-1-infected T cell
and an uninfected CD4
+ T cell in which virus particles are
concentrated at the VS. Reconstruction of a 3D model of the
contact zone between the cells revealed clustering in the infected
cell of organelles diagnostic for polarization of the T cell secretory
apparatus: multiple mitochondria, lysosomes, lipid bodies and the
MTOC [23,24,25,29](Fig. 1b and Video S1). To investigate
whether polarization was specifically associated with the VS, we
identified conjugates between HIV-1 infected T cells and
uninfected T cells with HIV-1 budding at the interface and
quantified whether the cells showed a polarized phenotype in
relation to the contact site (Fig. 1c, Fig. S1 and Video S2–S4). A
cell was defined as polarized when most of the cytoplasm was on
one side of the nucleus and all the mitochondria, lysosomes and
lipid bodies were associated with the cytoplasm-enriched area (Fig.
S1). Using this relatively stringent definition of polarization we
observed complete polarization of organelles towards the cell-cell
interface in 75% of HIV-1 infected T cells with budding virus at
the VS. Polarization was specific to the HIV-1 infected cell since it
was rarely seen in the conjugated target cell (18%) or in conjugates
between two uninfected cells (17%)(Fig. 1c). Notably, we did not
identify conjugates in which organelles were polarized away from
the contact interface. Single (unconjugated) HIV-1 infected T cells
with budding virus were also evident but in these cells polarization
of organelles at the budding site was seen only 30% of the time,
indicating that in the majority of infected cells adopt a polarized
phenotype in response to cell-cell contact.
Env colocalizes with SL-associated proteins in CD4
+ T
cells and at the VS
To investigate whether the regulated secretory pathway maybe
implicated in HIV-1 egress at the T cell VS, we incubated HIV-1
infected primary CD4
+ T cells with uninfected autologous CD4
+ T
cells and examined conjugates for VS formation by immunoflu-
orescence labelling (IF) and laser scanning confocal microscopy
(LSCM)[2]. Similar to our previous observations using infected
immortalized T cell lines [2], we found that polarization of Env to
the site of cell-cell contact occurred in approximately 30% of
conjugates examined (Fig. 2a). CTLA-4 and FasL are trafficked in
T cells by regulated secretion in secretory lysosomes (SL), and
coordinate with Env polarization, CTLA-4 and FasL were also
enriched at the VS (Fig. 2a) with 63% 69% of VS showing co-
localization of CTLA-4 with Env at the contact site. FasL staining
at the VS was generally weak, consistent with observations by
others, probably reflecting both the relatively short half-life of FasL
Author Summary
Human Immunodeficiency Virus type-1 (HIV-1), the cause
of the global AIDS pandemic, primarily infects CD4
+ T
lymphocytes and efficient replication necessitates trans-
mission of infection to susceptible neighbouring cells. To
ensure that the necessary components are transported to
the correct location in the cell and at the right time, viral
assembly is carefully controlled. To do this, HIV-1
preferentially assembles and buds at sites of cell-cell
contact called virological synapses. T lymphocytes employ
a specialized trafficking pathway known as the regulated
secretory pathway that is activated following cell-cell
contact. Here we show that HIV-1 proteins associate with
cellular compartments that are involved in regulated
secretion and that CD4
+ T cells from patients with a
genetic defect in this pathway are less able to support
spreading infection. We conclude that HIV-1 hijacks
elements of the T cell regulated secretory pathway to
promote T cell-to-T cell transmission at virological
synapses. This study provides the first evidence that
lymphotropic viruses can hijack regulated secretion to
enhance pathogenesis and may open up new opportuni-
ties for rational drug design to help combat HIV/AIDS.
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PLoS Pathogens | www.plospathogens.org 2 September 2011 | Volume 7 | Issue 9 | e1002226Figure 1. The HIV VS has a regulated secretion phenotype. A) The MTOC aligns proximal to the VS in the HIV-1 infected T cell. Primary CD4
+ T
cells infected with the HIV-1 strain BaL were mixed with uninfected autologous target CD4
+ T cells that were pre-stained with the non-inhibitory anti-
CD4 mAb L120 (green) and cells were incubated on poly-L-lysine-coated coverslips for 1 h at 37uC. Conjugates were fixed, permeabilized and stained
for intracellular HIV-1 Env (blue) and c-tubulin to label the centrosome (red). Two representative 3D reconstructed projections (top panels) and the
corresponding DIC images (lower panels) are shown of conjugates formed between an HIV-1 infected T cell and an uninfected target cell (asterisk)
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synthesized intracellular protein, which represents a subset of total
FasL [15].
The concomitant enrichment of CTLA-4 and FasL at the VS,
together with the previous observation that the endosome-
lysosome marker CD63 is also recruited to the VS [31] suggests
that HIV-1 proteins may be directed to cell-cell contact zones in
association with elements of the CD4
+ T cell regulated secretory
pathway. To address whether Env may be associating with SL-like
compartments in HIV-1 infected CD4
+ T cells, we first confirmed
that CD4
+ T cells contain a secretory compartment that is
antigenically similar to SL described in CD8
+ T cells and NK cells
[15,17,32] by performing colocalization analysis with CD63,
CTLA-4 and FasL (Fig. S2a, b and S3). Next, we examined the
localization of HIV-1 proteins with these markers in primary
CD4
+ T cells from healthy donors. Cells were analyzed for markers
of SL and Env by LSCM at the peak of virus infection (day 7–10
post-infection). Intracellular Env colocalized with SL-associated
proteins cathepsin D (r=0.58), CTLA-4 (r=0.48), FasL (r=0.54)
and CD63 (r=0.46) but not with a control antibody specific for the
mitochondrial protein ATP synthase subunit b (r=0.12) (Fig. 2b
and c). By contrast we observed very little colocalization of HIV-1
Gag with cathepsin D (Fig. 2d) in agreement with Env and Gag
trafficking independently to the plasma membrane in infected T
cells. Taken together these data suggest that HIV-1 Env may
localize to an intracellular compartment with SL properties,
referred to herein as an SL-related organelle (SLRO) in the context
of HIV-1 infection and that Env enrichment at the VS may be
associated with elements of the regulated secretion pathway in
CD4
+ T cells.
Defects in regulated secretion: Chediak Higashi
Syndrome
To evaluate whether the regulated secretory pathway plays any
functional role in HIV-1 dissemination we examined HIV-1
infection in the context of T cells that do not have fully functional
regulated secretory phenotype. Hematopoietic cells from individ-
uals with Chediak-Higashi Syndrome (CHS), a rare, autosomal
recessive condition characterized by partial albinism, prolonged
bleeding time and immune dysfunction, display abnormally large
CD63
+ SL that are unable to exocytose at the plasma membrane
[33]. The affected protein has been identified as the lysosomal
biogenesis regulator Lyst (or CHS-1), a 400kD protein that is
believed to regulate vesicle fusion/fission [33]. When examined by
LSCM, IL-2-dependent CD4
+ T cell lines derived from two
unrelated individuals with CHS contained CD63
+ compartments
that were characteristically reduced in number, often enlarged and
co-labelled for cathepsin D, CTLA-4 and FasL (Fig. 3a) as
reported previously [32,34]. In agreement with others [32] we also
found that surface expression of CTLA-4 and CD63 was not
upregulated in CHS cells even after 1 h treatment with PMA-
ionomycin (MFI CTLA-4 untreated =2.9, 1 h=3.0; CD63
untreated =212, 1 h=210) whereas cells from normal donors
rapidly increased surface expression following stimulation (Fig.
S4). After 4 h stimulation a slight increase in CD63 was detected
(MFI=335)(data not shown) probably reflecting trafficking via a
constitutive pathway that directs CD63 via the plasma membrane
en route to lysosomes [35] superimposed onto the defective
regulated secretory pathway. Collectively these data confirm the
presence of the expected defect in CHS cells and support our data
(Fig. S2) and those of others [17] that CD4
+ T cells, like CD8
+ T
cells contain a functional SL-related compartment for regulated
secretion.
Env localizes to SL-related compartments in CHS T cells
To examine the localization of Env in cells with abnormal SL-
related compartments, three CD4
+ T cell lines from two unrelated
CHS patients were infected with HIV-1 and examined by
immunofluorescence LSCM. We observed a partial accumulation
of Env (Fig. 3b and c), but not Gag (Fig. S5) with SL-associated
proteins in CHS cells that was reproducible using different CHS-
derived clones or PHA blasts, and using CXCR4 or CCR5-tropic
strains of HIV-1. The presence of Env colocalizing with cathepsin
D in CHS lysosomal organelles was also confirmed by ultrastruc-
tural analysis of cryosectioned HIV-1-infected CHS CD4
+ T cells
(Fig. 3d).
In HIV-1 infected cells Env is trafficked to the plasma
membrane and subsequently endocytosed by clathrin adaptor
complexes, similar to CTLA-4 [36,37,38,39,40,41,42]. To deter-
mine if HIV-1 Env may be associating with SL-related
compartments in CD4
+ T cells following endocytosis from the
plasma membrane, we first performed surface staining and flow
cytometry analysis and demonstrated that HIV-1 Env can be
detected at the plasma membrane of WT and CHS cells,
providing evidence either for a functional constitutive pathway
from the TGN to the plasma membrane in these cells or for
previous VS formation between these cells and target cells (Fig. 4a).
Next, HIV-1 infected WT or CHS cells (two different donors for
each cell type) were incubated with a mAb specific for the HIV-1
Env subunit gp120 for 24 h at 37uC to allow endocytosis of
antibody in complex with plasma membrane exposed gp120. We
used the mAb IgG1b12 that recognizes the CD4 binding site on
showing polarization of the MTOC in the infected cell (indicated by the large arrow). Clusters of HIV-1 Env in the infected cell (indicated by small
arrowheads) are located near to the cell-cell interface and around the MTOC. Scale bar=5 mm. MTOC polarization was quantified (lower left panel) in
conjugates that had formed a VS (black bar, defined by enrichment of viral proteins in infected cells at the contact site) or had not formed a VS (white
bar, no HIV-1 enrichment) and the MTOC was scored as polarized if it was aligned at the interface-proximal third in the HIV-1 infected cell. Data are
from three independent experiments and the error bars represent the SEM. The right hand graph shows the average distance of the MTOC from the
plasma membrane at the VS or at the contact site between two uninfected cells (control). Data are from three independent experiments. B)
Alignment of secretory organelles and MTOC proximal to the VS in the HIV-1 infected T cell. Infected Jurkat T cells were mixed with primary CD4
+ T cells,
fixed and embedded. Top panel is a VS overview image. The box indicates the region of the thick section shown in the 3D surface rendering (lower
panel) of a tomogram, reconstructed from two sequential tilt series taken from 300 nm sections. Redistribution of secretory organelles (endoplasmic
reticulum, ER, not pseudocoloured), secretory lysosomes (SL, orange), Golgi (G, not pseudocoloured), mitochondria (m, green) and lipid bodies (LB,
pale blue) and MTOC (blue), towards the site of virus particle (vi, red) release in the HIV-1 infected T cell. C) Quantification of cell polarization.
Conjugates between HIV-1 infected cells and target T cells with obvious virus budding (n=31), or conjugates between two cells without virus (n=55)
were examined by EM and quantified for whether or not cellular organelles were polarized to the site of cell-cell contact. Cells were defined as
polarized only when most of the cytoplasm and all the mitochondria, lipid bodies and lysosomes were localized to the contact site. Polarized = black,
unpolarized = white. Target cell = uninfected cell, donor = HIV-1 infected cell. Single unconjugated cells showing budding virus (n=96) were also
scored for whether organelles were polarized to the site of virus budding, or in the case of single cells without budding virus (n=216) whether any
cellular polarization was evident. Data are from two independent experiments in which two separate grids were examined. See also Fig. 1 and Video
S2–S4.
doi:10.1371/journal.ppat.1002226.g001
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surface of infected cells since endocytosed gp120-CD4 complex
could be potentially sorted into a different (CD4-mediated)
pathway to unliganded gp120. Taking this approach we observed
strong colocalization between endocytosed HIV-1 gp120 and
CD63 (r=0.7) and between gp120 and CTLA-4 in CHS cells
(Fig. 4b and c). By contrast less colocalization was evident between
gp120 and SL-associated proteins in WT cells (CD63 and gp120,
r=0.39). This suggests that a proportion of HIV-1 Env can access
SL-related compartments in CHS T cells after endocytosis from
the plasma membrane and that Env may preferentially accumu-
late therein in CHS cells.
CHS cells are less able to support a spreading HIV-1
infection
To investigate whether defects in regulated secretion from
CD4
+ T cells correlated with a functional defect in HIV-1 egress
and/or cell-to-cell spread we compared three different CHS CD4
+
T cell lines from two unrelated donors with WT cells from at least
four independent donors for their ability to support HIV-1
replication. CHS cells were appropriately matched with WT cells
(clones vs PHA blasts), stimulated and activated in parallel to allow
direct comparisons and infected with replication competent HIV-
1. Cell-free supernatants were taken on different days post-
infection and virus release was quantified by HIV-1 Gag p24
ELISA. Data from multiple infection experiments performed with
different CHS and WT cells were combined and quantification of
HIV-1 Gag p24 release revealed significantly less viral protein
present in the culture supernatant of CHS infected cells compared
to WT cells (Fig. 5a, p=0.008). This was independent of cell
number, growth kinetics, CD4 or HIV-1 co-receptor usage and
was evident with both CCR5 and CXCR4-tropic viruses (data not
shown). Quantification of viral infectivity revealed that the virus
produced by CHS cells was modestly but not significantly reduced
in infectivity when compared to virus released from wild-type cells
(Fig. 5b). Western blotting of cell-free virus purified by
ultracentrifugation from CHS and WT cultures (PHA blasts and
CD4
+ T cell clones) confirmed the presence of proteolytically
processed HIV-1 gp120 in viral particles demonstrating that
functional Env can be incorporated into cell-free virions (Fig. 5c);
however, variation in Gag p24 and Env gp120 levels between virus
samples from different donors precluded accurate analysis of the
relative amount of HIV-1 Env incorporation. We did not observe
any obvious increase in unprocessed Gag p55 indicating CHS cells
produce proteolytically-mature cell-free virus. Although both WT
and CHS cells produced infectious virus, more HIV-1-infected
CD4
+ T cells were present in WT cultures (3865%) compared to
CHS cultures (15% 63%, p=0.004)(Fig. 5d) and a trend towards
less frequent cell-cell interactions and VS formation (defined as
colopolarization of Env and Gag at sites of cell-cell contact) was
evident with HIV-1-infected CHS cells. By contrast, conjugates
between HIV-1 infected WT cells and target CD4
+ T cells were
more readily formed and polarization of viral proteins to the VS
was apparent in 42% of conjugates examined (n=57). When
examined by LSCM, we noted that when VS did form between
HIV-1 infected CHS cells and uninfected autologous T cells viral
proteins seemed to be less polarized at sites of cell-cell contact than
in WT cells (Fig. 5e); however limited patient samples meant that
we were unable to quantify this observation.
The difference we detected by p24 ELISA in the amount of
extracellular HIV-1 capsid protein in CHS cultures compared to
WT and the difference in the number of infected cells could be
caused by a block in initial infection of CHS cells, by a reduction
in cell-free virus production from infected cells, or by a defect in
the ability of CHS cells to efficiently disseminate infection to
neighboring cells by cell-to-cell spread. To address these pos-
sibilities we first quantified infection of CHS and WT cells using
single-cycle, replication defective pseudotyped HIV-1 that con-
tains a luciferase reporter gene, allowing infection to be measured
by luminescence assay without a spreading infection taking place.
CHS and WT CD4
+ T cells were incubated with virus for 4 h,
unbound virus was removed by washing and infection was
measured by luciferase activity after 24 h. Fig. 6a shows that
both WT and CHS cells were similarly susceptible to infection
with pseudotyped virus, demonstrating that CHS cells can support
infection leading to proviral integration and suggesting that a
block to infection is not responsible for the defect in HIV-1
replication in CHS cells.
We next addressed whether Lyst-defective cells may have a late-
stage defect in cell-free virus assembly and release. CHS and WT
cells were again infected with single-cycle, replication-defective
pseudovirus and Gag p24 release was examined by SDS-PAGE
and Western blotting. This infection assay faithfully mimics cell-
free virus production over a single round of infection because
although Gag virus-like particles are released from cells they are
Env
- and so cannot initiate a spreading infection. Fig. 6b shows
that Gag p24 could be detected in cell-free supernatants and in cell
lysates from WT and CHS cells with no difference in the ratio of
cell-free to cell-associated Gag (Fig. 6b), demonstrating that the
reduced levels of infection seen with replication-competent HIV-1
is not due to a defect in Gag synthesis or a block in cell-free virus
budding from CHS cells.
Finally, to directly quantify cell-to-cell spread CHS and WT
CD4
+ T cells were infected with the replication competent HIV-1
strain NL4-3, incubated for 48 h to allow viral protein expression
and nascent HIV-1 production, and an equal number of infected
cells were mixed with uninfected 1G5 target T cells. 1G5 cells
contain an HIV-1 Tat-inducible firefly luciferase reporter gene
Figure 2. HIV-1 Env associates with SL-related organelles in CD4
+ T cells. A) SL-associated proteins are co-enriched with Env at the VS. HIV-1
infected CD4
+ T cells were mixed with uninfected autologous target T cells and incubated on coverslips at 37uC for up to 2 h. Conjugates were fixed,
permeabilized and stained for Env (red) and FasL or CTLA-4 (green). Images are single xy sections taken through the middle of a conjugate with the
corresponding DIC image. The target cell is indicated with an asterisk. Areas of colocalization are yellow. Scale bar=5 mm. B) HIV-1 Env colocalizes
intracellularly with SL-associated proteins. Single CD4
+ T cells infected with HIV-1 were fixed, permeabilized and stained for intracellular Env (red) and
CD63, cathepsin D, CTLA-4 or FasL (green). Primary antibodies were detected with species or isotype-specific conjugated secondary antibodies.
Images are 3D reconstructions of serial z-sections taken by LSCM with the corresponding merged and DIC images shown. C) Quantification of
colocalization between Env and CD63 (n=21), cathepsin D (n=25), CTLA-4 (n=20) and FasL (n=20) are shown. As a control, colocalization between
Env and the mitochondrial protein ATP synthase subunit b was also quantified. For each infected cell, quantification of colocalization was performed
on a single xy slice extracted from the corresponding z series and the Pearson’s correlation coefficient (r) was calculated. The average r values are
graphed and error bars show the SEM from four experiments performed using six individual donors. D) HIV-1 Gag does not colocalize with cathepsin D.
HIV-1 infected CD4
+ T cells were fixed, permeabilized and stained for HIV-1 Gag (red) and cathepsin D (green). The corresponding DIC image is
shown.
doi:10.1371/journal.ppat.1002226.g002
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after 24 h, a time frame in which only a single round of infection
will take place [7,8,44,45,46,47]. Coculture of 1G5 target cells
with HIV-1 infected CHS donor cells gave a 10-fold reduction in
RLU compared to target T cells that were incubated with WT
donor cells, indicating that HIV-1 infected CHS T cells were less
efficient at transmitting infectious virus by cell-to-cell spread
(Fig. 6c). It should be noted that target T cells incubated with
HIV-1 infected WT cells from donor 1 displayed less efficient
transmission than other WT cells tested. We observed that prior to
infection with HIV-1 the cells from this donor stimulated and
proliferated less robustly than the others (data not shown) and this
that may have impacted on the ability of these cells to transmit
virus. It is also possible that these cells contained another
polymorphism that may affect the efficiency of HIV-1 replication
and spread.
Defects in regulated secretion inhibit cell-to-cell spread
of HIV-1
To explore the possibility that the Lyst protein mutated in CHS
patients confers a block in cell-to-cell transmission and to provide a
second line of evidence that the defect in HIV-1 spread in CHS
cells was restricted to Lyst function, we carried out RNAi knock-
down of Lyst by transducing T cells with lentivirus expressing lyst-
specific shRNA and directly analyzed cell-to-cell spread of virus.
HIV-1-infected Jurkat T cells stably expressing a pool of 4
different Lyst-shRNA sequences displayed a 25% reduction in Lyst
mRNA compared to control Jurkat cells expressing scrambled
shRNA sequences (Fig. S6a). Although Lyst-shRNA knockdown
represented a modest reduction in Lyst mRNA levels, this was
reproducible and may translate into a more extreme phenotype in
reduction in protein levels. Unfortunately we are unaware of the
existence of an antibody to Lyst that could be used for detection of
this protein in WT and shRNA-transduced cells; however, Lyst-
shRNA cells do show an altered CD63 distribution compared to
control cells indicative of a defect in this pathway (Fig. S6b). To
quantify cell-to-cell spread, Lyst-shRNA cells or control-shRNA
expressing cells were infected with HIV-1 and incubated for 10
days to establish a chronic infection before being used as donor
cells in cell-to-cell transmission assays when .90% of the cells
were infected as measured by intracellular Gag staining and flow
cytometry (data not shown). This allowed us to examine cell-to-cell
spread to target cells while obviating spreading infection within the
donor cell population. Infected donor cells were mixed with
normal uninfected Jurkat target T cells for 0, 1, 3 and 6 h (a time
frame that permits efficient cell-to-cell but not cell-free infection
[7,8,44,45,48]) and genomic DNA was extracted and HIV-1 DNA
reverse transcripts were quantified by real-time qPCR. The
baseline values at t=0 h were subtracted from each time point (to
account for variation in the amount of HIV-1 provirus in infected
cells) and normalized to a housekeeping gene to determine the
HIV-1 DNA index, a measure of the copy number of HIV-1 DNA
[7,45]. Fig. 7a shows Lyst-shRNA cells were significantly impaired
in their ability to transmit virus to target T cells by cell-to-cell
spread when compared to donor cells expressing control-shRNA
(6 h DNA index 12.362.7 compared to 42.8612.5, p=0.001).
To confirm these results using a second assay system, Jurkat cells
expressing control-shRNA or Lyst-shRNA were infected with
HIV-1, incubated for 3 days and mixed with uninfected 1G5
target T cells. We confirmed that very little luciferase activity
within 24 h was from cell-free virus produced by donor cells,
verifying that this assay efficiently detects only cell-to-cell spread
(data not shown). Fig. 7b shows that in agreement with the real-
time PCR results, Lyst-shRNA cells were significantly impaired in
their ability to transmit infection to target 1G5 T cells by cell-to-
cell spread when compared to cells expressing control-shRNA
(p,0.001). Pre-treating target cells with the reverse transcriptase
inhibitor Zidovudine reduced luciferase activity by .50% in target
cells confirming that this assay detects HIV-1 infection that
correlates with appropriate RT-dependent infection rather than
cell-cell fusion that could drive RT-independent Tat-induced
luciferase expression. Furthermore we have previously shown that
most VS exist for ,3 h and do not result in cell-cell fusion [45].
We used acutely-infected donor cells at 3 days post-infection when
10–30% of cells were infected, measured by intracellular Gag
staining and flow cytometry analysis. Limiting the time for
spreading infection within the donor population meant that
equivalent numbers of infected cells were inputted into the assay
enabling a direct comparison of the ability of different shRNA
expressing cells to transmit virus. Moreover, because only the
target cells contain the HIV-1 driven reporter construct we can
unequivocally measure transmission to these cells and not ongoing
spreading infection within the donor population. Using acutely-
infected cells rather than chronically-infected cells as donors also
demonstrated that the defect in cell-to-cell spread seen using the
qPCR assay (Fig. 7a) was not dependent on the chronicity of the
infection.
Finally, there was no difference in the relative infectivity of cell-
free supernatants when titered on HeLa tzm-bl cells (Fig. 7c),
confirming that the defect in cell-to-cell spread we observed when
using Lyst-shRNA expressing cells as donor cells was not because
the virus produced by these cells was non-infectious. Furthermore,
when Lyst-shRNA and control-shRNA cells were infected with
replication defective pseudotyped virus we did not observe any
difference in Gag synthesis and release by Western blotting
(Fig. 7d), showing that Lyst-shRNA expressing cells are not
defective in producing cell-free virus over a single replication cycle.
Taken together these data indicate that in the absence of
functional Lyst protein HIV-1 infected CD4
+ T cells are impaired
in transmitting virus between T cells by cell-to-cell spread.
Figure 3. HIV-1 Env colocalizes with enlarged SL-related organelles in CHS cells. A) CD4
+ T cells from CHS individuals contain enlarged
lysosomes. CD4
+ T cells were activated for 24 h with anti-CD3 mAb at 7–14 days post-stimulation, fixed, permeabilized and stained by
immunofluorescence for CD63, CTLA-4 and FasL. Images are 3D reconstructed z-series, areas of colocalization appear yellow and the corresponding
DIC images are shown. Enlarged CD63
+ SLs are present without CD3 activation, but CTLA-4 and FasL expression are increased following activation
(data not shown). B) HIV-1 Env colocalizes with SL in CHS CD4
+ T cells. CD4
+ T cell clones were infected with HIV-1 and 10–12 days post-infection the
cells were fixed, permeabilized and stained by IF for Env (red) and CD63, FasL or cathepsin D (green). Images are 3D reconstructed z-series and areas
of colocalization are yellow. C) Quantification of colocalization (the average r value) is shown for Env and CD63 (n=21), cathepsin D (n=25) and FasL
(n=21) and was performed as described in Fig. 2. Data are from four independent experiments performed with three cell lines from two unrelated
CHS patients. D) Cryo-immuno EM of Env and cathepsin D staining in HIV-1-infected CHS cells. CHS cells were infected with HIV-1, fixed, frozen and
cryosectioned and stained with anti-cathepsin D (detected with 10 nm gold) and the HIV-1 Env mAb2G12 (detected with 5 nm gold). Left panel
shows the presence of multiple, enlarged cathepsin D-positive compartments in the CHS cell. This is shown in more detail in the middle panel with
Env (5 nm gold) staining highlighted with arrowheads. Two boxed regions are magnified in the right panel to more clearly show cathespin D (10 nm
gold) and Env (5 nm gold and arrowheads) colocalization. Scale bar=600 nm.
doi:10.1371/journal.ppat.1002226.g003
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PLoS Pathogens | www.plospathogens.org 8 September 2011 | Volume 7 | Issue 9 | e1002226Figure 4. HIV-1 Env colocalizes with SL-associated proteins following endocytosis from the plasma membrane. A) HIV-1 infected WT and
CHS CD4
+ T cells express HIV-1 Env at the plasma membrane, evidence of functional constitutive trafficking. WT and CHS cells infected with HIV-1 were stained
with the mAb 2G12 and anti-human conjugated-PE on ice at 7 days post-infection to label surface expressed gp120 and analyzed by flow cytometry. HIV-1
gp120 surface staining on infected cells (black line) is overlaid onto uninfected cells also stained with 2G12 (grey filled). Histograms are representative of
independent experiments performed with two WT and two CHS cell lines. B) Confocal analysis of endocytosed Env colocalizing with SL-associated proteins. WT
CD4
+T cells (top two panels) and CHS cells (lower two panels) were infected with HIV-1, incubated for 4–5 days, washed and incubated for 24 hours in media
containing 10 mg/ml of the HIV-1 gp120 specific mAb IgGb12. The cells were then fixed, permeabilized and stained with anti-CD63 or anti-CTLA-4 (green).
Endocytosed, intracellular Env was detected with anti-human secondary antibody (red) and CD63 and CTLA-4 with anti-mouse secondary antibody. Images
are 3D reconstructed z-series representative of experiments performed with cells from two CHS patients and two WT donors. Areas of colocalization are
yellow and the corresponding DIC images are shown. C) Quantification of colocalization between endocytosed Env and SL-associated proteins (average r
value) is shown for Env and CD63 in WT cells (n=9) and CHS cells (n=18) and was performed as described in Fig. 2. Error bars show the SEM.
doi:10.1371/journal.ppat.1002226.g004
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+ T cells are less able to support HIV-1 replication in culture. A) CHS CD4
+ T cells (black bars) and cells from normal WT
donors (white bars) were infected with HIV-1 and supernatants were taken at various days post-infection and virus release was quantified by HIV-1
Gag p24 ELISA. Values in the upper panel were normalized to viable cell count and are ng p24/ml/10
6 cells and show Gag p24 from supernatants
taken at 10–12 days post-infection. The lower panel shows the Gag p24 levels from the same experiments at all time points. Data are from four
independent experiments performed using four different WT donors and three different CHS cell lines from two unrelated patients. Error bars show
the SEM. B) CHS cells produce infectious virus. Cell-free supernatants were harvested at 10–12 days post-infection and viral infectivity was quantified
on HeLa Tzm-bl reporter cells by luciferase assay. The TCID50 was calculated and data are shown as the TCID50 per ng of p24 to normalize for
differences in the amount of virus in the supernatant. Data are from three independent experiments performed using four different WT donors and
three different CHS cell lines from two unrelated patients. Error bars show the SEM. C) Western blotting analysis of HIV-1 Env incorporation into purified
virions. Viral particles from HIV-1 infected cultures were purified by ultracentrifugation and concentrated 10-fold. An equal volume was loaded onto
polyacrylamide gels and viral proteins were separated by SDS-PAGE. Western blotting was performed with rabbit anti-Env and rabbit anti-Gag serum
and proteins were visualized by ECL. Western blots of two WT donors and two CHS patients are shown and are representative of results obtained
using four WT virus samples and four CHS virus samples. One example of PHA blasts (left panels) and one example of cloned CD4
+ T cells (right
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HIV-1 between T cells
To further validate a role for regulated secretion in HIV-1 VS-
mediated T cell-to-T cell transmission we used lentivirus-encoded
shRNA to knock down syntaxin 4, a plasma membrane-associated
SNARE protein that localizes to the T cell IS and contributes to
lysosome exocytosis by regulated secretion [49,50,51]. CD4
+ T
cells expressing syntaxin-4-specific shRNA expressed 70% less
syntaxin-4 protein than control cells (Fig. S7). Similar to Lyst-
shRNA expressing cells, syntaxin-4 knockdown cells were also
significantly impaired in their capacity to transmit infectious HIV-
1 to target T cells by cell-to-cell spread measured by qPCR (6 h
DNA index 1.960.3, compared to 10.361.1, p=0.001) (Fig. 8a)
and by luciferase assay using 1G5 reporter T cells (Fig. 7b,
p,0.001). Quantitative assays performed on cell-free viral
supernatants harvested from Syntaxin 4-shRNA confirmed that
panels) are shown. Note that HIV-1 Env gp120 and unprocessed gp160 can be detected in all virus samples. D) Quantification of HIV-1 infected cells.
CHS cells and WT cells were fixed, stained for HIV-1 Gag and the number of Gag
+ infected cells was quantified by LSCM. Data are from three
independent experiments with the SEM. E) Confocal microscopy of a VS formed between an infected CHS T cell and a target T cell. HIV-1 infected CHS
CD4
+ T cells were mixed with an equal number of uninfected CHS CD4
+ T cells (prestained with the CD4 mAb L120 (green)) and conjugates were
incubated for 1 h at 37uC (upper panel). Cells were then fixed, permeabilized and stained for HIV-1 Env with 2G12 (red) and HIV-1 Gag (blue) and
examined by LSCM. The target cell is indicated with an asterisk on the corresponding DIC image. A representative VS formed between two WT cells is
shown for comparison (lower panel).
doi:10.1371/journal.ppat.1002226.g005
Figure 6. CHS cells support HIV-1 infection and Gag budding over a single- round of replication but transmit virus less efficiently
by cell-to-cell spread. A) CHS CD4
+ T cells are susceptible to infection with pseudotyped virus. 10
6 CD4
+ T cell blasts from three WT donors and one
CHS patient were infected in duplicate with replication-defective VSV-G pseudotyped HIV-1 encoding the luciferase gene. Infection was quantified
after 24 h by luminescence assay and the relative light units are shown with the SEM. Data are from two independent experiments performed with
three unrelated WT donors and one CHS donor. B) CHS and WT cells release equivalent amounts of Gag p24 over a single infection cycle. 10
6 WT and
CHS CD4
+ T cells were infected in triplicate with replication-defective VSV-G pseudotyped HIV-1 and cell and viral lysates were separated by SDS-
PAGE and probed with rabbit anti-Gag by Western blotting. The relative amount of cell-free-to-cell-associated Gag was quantified using Image J.
Equal loading of cell lysates was verified by probing membranes with anti-actin antibody. A representative blot is shown with quantification from
three independent experiments performed with four WT donors and one CHS patient. Error bars show the SEM. C) CHS cells transmit virus less
efficiently to target T cells by cell-to-cell spread. CD4
+ T cell blasts from three WT donors and one CHS patient were infected with HIV-1 strain NL4.3 for
48 h and an equal number of donor cells were mixed with 1G5 target T cells for 24 h.1G5 cells express an HIV-1 Tat-inducible firefly luciferase reporter
gene and cell-to-cell spread of HIV-1 from donor T cells to target T cells was measured by luminescence assay. Data from one of two independent
experiments is shown and error bars show the SD.
doi:10.1371/journal.ppat.1002226.g006
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non-infectious virus (Fig. 8b) nor were syntaxin-4 knockdown cells
impaired in cell-free virus synthesis and budding when infected
with single-cycle replication defective pseudovirus (Fig. 8c). We
also observed that VS formation by syntaxin-4 knockdown cells
was less frequent (19% 66% of contacts evolving a VS) than cells
expressing control-shRNA (68% 62% evolving a VS p=0.009).
Taken together with the results using Lyst-shRNA expressing cells,
these data support the concept that the cellular machinery
implicated in regulated secretion from T cells contributes directly
to T cell-to-T cell spread of HIV-1 at the VS.
Discussion
Here we provide evidence that the regulated secretory pathway
in CD4
+ T cells contributes to cell-to-cell spread of HIV-1 at the
VS. We have shown that HIV-1 infected T cells polarize their
MTOC and associated organelles at sites of cell-cell contact that
aligns the secretory apparatus proximal to the VS; that HIV-1 Env
colocalizes with SL-related organelles in CD4
+ T cells; and that
CD4
+ T cells disabled for regulated secretion are less able to
support spreading HIV-1 infection. The striking polarization that
we observed at the VS is reminiscent of cytoskeletal remodelling at
Figure 7. Defects in regulated secretion inhibit cell-to-cell spread of HIV-1. A) Lyst modulates cell-to-cell spread of HIV-1 measured by
quantitative real-time PCR. HIV-1 infected Jurkat T cells stably expressing Lyst-shRNA (black bars) or control-shRNA (white bars) were mixed with an
equal number of uninfected target T cells and incubated for 0, 1, 3 and 6 hours prior to lysis and extraction of DNA. Quantitative real-time PCR
using pol primers was performed to quantify de novo HIV-1 DNA synthesis as a measure of HIV-1 cell-to-cell spread. The HIV-1 DNA copy number
was normalized to human serum albumin (HSA) and is shown as the ratio of HIV-1 DNA to HSA DNA. The data obtained at t=0 h (baseline) were
subtracted from the test values. Data are from three independent experiments and error bars show the SEM. B) Quantification of cell-cell spread
using a luciferase reporter T cell line. HIV-1 infected Jurkat T cells expressing control-shRNA, Lyst-shRNA or Syntaxin 4-shRNA were mixed with an
equal number of uninfected 1G5 target T cells that were either untreated (white bars) pre-treated with 50 mM Zidovudine (grey bars) and
incubated for 24 h. 1G5 cells express an HIV-1 Tat-inducible firefly luciferase reporter gene and virus infection was measured by luminescence. Data
show the relative light units from a representative of two independent experiments and error bars show the SD. C) Lyst knockdown cells produce
infectious cell-free virus. Cell-free supernatants were harvested from cells infected with replication competent HIV-1 at 7 days post-infection and
viral infectivity was quantified on HeLa Tzm-bl reporter cells by luciferase assay. The TCID50 was calculated and data are shown as the TCID50 per
ng of p24 to normalize for any differences in the viral content of supernatants. Data are from three independent experiments and show the SEM.
D) Lyst and control knockdown cells produce equivalent amounts of p24 over a single infection cycle. Lyst-shRNA cells and control-shRNA cells were
infected with replication-defective VSV-G pseudotyped HIV-1 for 48 h. Cell and viral lysates were separated by SDS-PAGE and probed for Gag p24
by Western blotting. The relative amount of cell-free-to-cell-associated Gag was quantified using Image J. Equal loading of cell lysates was verified
by probing membranes with anti-actin antibody. A representative blot is shown with quantification from two independent experiments with the
SEM is shown.
doi:10.1371/journal.ppat.1002226.g007
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TCR and integrin interactions trigger contact-mediated polariza-
tion of the MTOC and secretory apparatus for regulated secretion
of vesicular cargo from T cells. At the IS, microtubules associated
with the MTOC deliver secretory vesicles to the plasma mem-
brane, a process has been elegantly imaged in CTLs [23,24].
Although the MTOC in the HIV-1 infected T cell was frequently
oriented towards the VS we rarely observed very close membrane
apposition of the centrosome with the plasma membrane, rather
the MTOC was located on average 1 mm from the plasma
membrane at the VS. This is in broad agreement with calculations
made at the IS in which very close apposition of the MTOC at the
plasma membrane was not the predominant phenotype but was
seen in approximately 17% of CTL synapses examined [23], and
in most cases the MTOC was polarized towards the contact site
but distal from the secretory domain at the plasma membrane
[23]. Partial polarization (without obvious plasma membrane
docking) of the MTOC at both the IS and the VS might be
explained by oscillation of the MTOC at sites of cell-cell contact
(to facilitate continual scanning of the synapse) [52] and/or the
effect of chemical fixation only revealing a snapshot of dynamic
processes. Alternatively, actual docking of the MTOC at the VS
may not be essential for HIV-1 cell-to-cell spread. For example, it
has been proposed that secretory compartments may be delivered
to synapses either by short microtubules that contact the plasma
membrane (presumably requiring close MTOC-PM apposition),
via longer microtubules that curve past the synapse or by granules
that dock at the edge of the synapse and move tangentially before
fusing at the plasma membrane [23,53]. In any (or all) of these
ways, MTOC polarization near to the contact site may help
deliver viral and/or cellular proteins to the VS by microtubule-
based vesicular movement [7] and MTOC-driven organelle
recruitment.
Concomitant with cytoskeletal remodelling at the VS we
observed striking polarization of organelles diagnostic for regulat-
ed secretion at the IS [25,29,54,55]. Notably, this polarization was
only seen within the HIV-1 infected T cell and was associated
predominantly with cell-cell contact, suggesting that polarization
may be driven by interactions at the HIV-1 T cell VS. The T cell
IS (particularly the cytotoxic IS) is characterized by a broad,
integrin-rich peripheral ring with a central secretory domain that
serves as a focal point for regulated secretion. By contrast, our EM
tomography of the HIV-1 VS and other studies [2,9,45] reveals an
interface that is structurally similar but with smaller, numerous
areas of cell-cell contact that is accessible to soluble proteins [45].
Planar bilayer studies have elegantly demonstrated actin clearing
and molecular segregation at the T cell VS reminiscent of the p-
and cSMACs seen at the IS [56,57]. Therefore whilst similarities
between the ultrastructure of the IS and the T cell VS exist, there
are also clear differences that probably reflect the effects of
different receptor-ligand interactions.
Collectively, our data generated using WT and CHS patient-
derived cells and RNAi suggests that cell-to-cell spread of HIV-1
at the VS may functionally intersect the T cell regulated secretory
pathway. Hijacking this machinery and T cell polarization would
permit HIV-1 exquisite temporal and spatial control over virus
assembly and exit, both by polarizing dissemination at the VS, as
we have previously reported [2], and potentially by limiting the
Figure 8. Syntaxin 4 contributes to cell-to-cell spread of HIV-1. A) HIV-1 infected Jurkat T cells expressing syntaxin 4-shRNA (black bars) or
control-shRNA (white bars) were used to measure cell-to-cell spread of virus by quantitative real-time PCR as described in Fig. 7. Data are from three
independent experiments and error bars show the SEM. B) Syntaxin 4 knockdown cells produce infectious cell-free virus. Cell-free supernatants were
harvested from cells infected with replication competent HIV-1 at 7 days post-infection and viral infectivity was quantified on HeLa Tzm-bl reporter
cells by luciferase assay. The TCID50 was calculated and data are shown as the TCID50 per ng of p24 to normalize for any differences in the viral
content of supernatants. Data are from three independent experiments and show the SEM. C) Syntaxin-4 and control knockdown cells produce
equivalent amounts of p24 over a single infection cycle. Syntaxin-4-shRNA cells and control-shRNA cells were infected with replication-defective VSV-G
pseudotyped HIV-1 for 48 h. Cell and viral lysates were separated by SDS-PAGE and probed for Gag p24 by Western blotting. The relative amount of
cell-free-to-cell-associated Gag was quantified using Image J. Equal loading of cell lysates was verified by probing membranes with anti-actin
antibody. A representative blot is shown with quantification from two independent experiments with the SEM is shown.
doi:10.1371/journal.ppat.1002226.g008
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the infected cell contacts an uninfected, receptor-expressing target
cell. Based on the data presented here, we hypothesize that the
activation of a contact-dependent secretory pathway may con-
tribute to directing retroviral proteins to intercellular junctions.
Polarization of HIV-1 assembly and budding at sites of cell-cell
contact has been described [2,4,8,9,58,59,60,61,62,63,64] but the
cellular processes underlying this are ill-defined. Similarly,
preferential assembly of the related retrovirus MLV at sites of
cell-cell contact has also been reported but again the underlying
mechanism for this is unknown [65]. At the T cell IS polarization
and activation of regulated secretion is triggered by T cell receptor
engagement with degranulation and secretion determined by the
strength of TCR signal [28,53]. In addition, adhesion molecules
such as the LFA-1 and ICAM play a central role alongside
pMHC-TCR in triggering polarization and regulating secretion at
IS [66,67,68,69]. The TCR is not specifically enriched at the
HIV-1 T cell VS and homotypic T cell-T cell interactions and the
T cell VS are antigen-independent structures. VS assembly is
driven by Env-receptor and LFA-1-ICAM interactions [2,70] and
we hypothesize a model in which small amounts of Env present at
the plasma membrane may initially engage viral receptors on the
target T cell and together with integrins help provide a stable
adhesive environment, recruit and activate additional adhesion
molecules and potentially signal into the infected cell to polarize
elements of the secretory apparatus proximal to the VS, as
demonstrated for HTLV-1 and implied by studies using
immortalized HIV-1 infected T cell lines [7,71,72]. This in turn
could help deliver viral and cellular proteins via the regulated
secretory pathway to the plasma membrane at the VS.
HIV-1 Env mediates attachment to, and entry into susceptible
cells, directs the site of virus budding at the plasma membrane,
and drives VS formation leading to cell-to-cell viral spread;
however, little is known however about how Env is directed to the
sites of HIV-1 assembly at the plasma membrane, and by exten-
sion to the VS. Here we show that CD4
+ T cells contain a
functional SLRO in which HIV-1 Env and SL-associated proteins
colocalize both intracellularly and at the VS suggesting that the
pathways of regulated secretion and Env trafficking may intersect.
We report that two proteins trafficked by regulated secretion in T
cells, CTLA-4 and FasL are also enriched along with Env at the
VS. Colocalization of HIV-1 and CD63 at sites of virus budding
and the VS has been observed previously by ourselves and others
suggesting that the pathway of HIV-1 egress and vesicular
trafficking may overlap [31,73,74,75]. Env is normally trafficked
to the surface of infected cells but is endocytosed via association
with clathrin adaptor proteins [36,37,38,40,41,42,46,76]. This is
similar to the transport pathways employed by CTLA-4 that can
access SL-related compartments either by trafficking directly from
the Golgi or after passage via the plasma membrane and associa-
tion with clathrin adaptor complexes [16,17,77]. We detected the
Env subunit gp120 on the surface of WT and CHS CD4
+ T cells
infected with HIV-1, providing evidence for functional constitutive
transport. However, Env appeared to accumulate in SLRO in
CHS T cells following endocytosis from the plasma membrane
suggesting that HIV-1 Env may initially traffic to the plasma
membrane in infected T cells, from where it gets endocytosed
ending up in lysosome-like compartments. The colocalization we
observed between Env and SLRO, coupled with the polarization
of secretory apparatus and the MTOC within the infected T cell
towards the VS during cell-cell contact, and the defect in cell-to-
cell spread when regulated secretion was disabled may be
explained by cell-to-cell spread at the VS intersecting the regulated
secretory pathway in T cells. In cells defective for regulated
secretion (e.g. CHS cells) Env might accumulate in immobile
secretion-defective SLRO and/or be incorrectly sorted to other
compartments. In this way, Env may not be effectively recycled
back to the plasma membrane or mobilized to the VS following
stimulation of regulated secretion. Based on our data, we cannot
exclude thepossibility that thedefectinregulated secretion mayalso
be affecting cell-to-cell spread of HIV-1 in an Env-independent
manner and that regulated secretion at the T cell VS may similarly
control the delivery or endocytosis of other proteins (for example
adhesion molecules) that in turn could affect the frequency or
duration of cell-cell contacts. Moreover, although HIV-1 Gag did
not colocalize with Env in SLRO, it is possible that activation of
regulated secretion during cell-cell contact may also direct Gag to
VS but via an alternate transport pathway [9,64,65].
In polarized T cells HIV-1 Gag localizes to uropods and this is
suggested to facilitate cell-to-cell transmission of virus [78].
Uropods are cellular projections rich in adhesion molecules and
organelles and are found in activated T cells that have established
front-rear polarity (e.g. during chemotaxis). Notably, Gag
enrichment in uropods was reported to be Env-independent
[78], and it was suggested that Env may not be required for initial
contact via integrin-rich uropods, presumably because a critical
concentration of adhesion molecules were already present. By
contrast, Env-receptor interactions have been shown by us and
others to be necessary for stable T cell-T cell contacts, VS
formation and transmission of infectious HIV-1 by cell-to-cell
spread [2,4,8,9,45]. Our EM tomography and confocal micros-
copy data show that cell-cell contact is associated with striking
organelle and cytoskeletal polarization within the HIV-1 infected
T cell that correlates with virus budding at the VS. T cell
polarization at sites of virus budding was much less evident in
unconjugated T cells, suggestive of contact-induced rearrange-
ments. Thus it appears that T cell contacts leading to VS formation
and HIV-1 transmission may be initiated by (at least) two
mechanisms: In the first model supported by the data presented
here, contact between an HIV-1 infected T cell and a target T cell
may trigger cytoskeletal remodelling and enrichment of the MTOC
and secretory organelles towards the contact site establishing a
polarized phenotype within the HIV-1 infected T cell. In this
situation, the initial contact could be mediated by Env-CD4 and/or
LFA-1-ICAM interactions with further recruitment of additional
Env and integrins to stabilize the contact site and establish the VS.
The induction of a polarized phenotype could then help focus Env
secretion via activationof a regulated transportpathway for efficient
virus assembly and cell-to-cell spread. In the second model
supported by the data of Llewellyn et al., enriched integrins at
uropods in pre-polarized HIV-1 infected cells could themselves
initiate contact between HIV-1 infected T cells and target T cells
and stabilize conjugate interfaces. Because the MTOC and
organelles would be already located at the uropod in such polarized
T cells the secretory apparatus could be poised to contribute to Env
trafficking towards the plasma membrane at the contact site for
infectious virus assembly. It should be noted that these models are
not mutually exclusive and it is possible that different processes may
operate under different conditions depending on whether a T cell is
polarized before or during cell-cell contact. Future work will seek to
determine what triggers contact-dependent polarization at the T
cell VS and how this may contribute to activation of secretion and
HIV-1 protein trafficking to sites of cell-cell contact. Live cell
imaging of Env trafficking to VS would shed much light on this area
but such studies will be considerably more challenging.
The cellular protein Lyst is thought to function in the secretory
pathway by regulating membrane fusion/fission, and defects in
lysosome morphology may be influenced by interactions between
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required for transport) pathway, a group of cellular proteins that
normally regulate vesiculation and cytokinesis but also promote
HIV-1 budding at the plasma membrane [79]. Here we provide
new evidence that Lyst may also be involved in regulating cell-to-
cell spread of HIV-1, perhaps by modulating Env trafficking. It is
worth noting that the ESCRT machinery and MVB-associated
lipids are also recruited to the IS [80,81] and MVB-like structures
related to SL form at the CD4
+ T cell IS where TSG101
recognition of ubiquitinated protein is necessary for TCR down-
regulation and cSMAC formation [80]. In the context of HIV-1
egress, TSG101 is recruited to sites of virus budding by association
with late-domain motifs in Gag and is necessary to mediate the
release nascent HIV-1 particles from the plasma membrane of
infected cells. Whether ESCRT helps regulate cell-to-cell spread of
HIV-1 at the T cell VS by other as yet undefined mechanisms is
an intriguing possibility that warrants further investigation. Within
cells the delivery of vesicular cargo is controlled by the SNARE
protein family - a group of proteins that promote fusion between
vesicles and target cell membranes through specific t-SNARE and
v-SNARE interactions. The SNARE proteins syntaxin 4 is
implicated in regulated secretion from haematopoetic cells and
at the IS [49,50,82,83] and we have demonstrated that syntaxin 4
also contributes to HIV-1 egress at the VS. Deregulating SL func-
tion via natural Lyst mutation, or with RNAi, and inhibition of
syntaxin 4 mediated vesicle fusion identified these two proteins as
molecules that contribute to HIV-1 spread at the VS. Interesting-
ly, secretion of soluble proteins by CD4
+ T cells at the IS requires
different cellular machinery depending whether proteins are
secreted in a polarized or multidirectional manner [22] and this
may be true also for HIV-1 egress at the VS since we saw no effect
of Lyst or syntaxin 4 on cell-free HIV-1 release but observed a
clear defect in cell-to-cell spread. Future studies will aim to
uncover other proteins that are involved in the pathway of HIV-1
egress at the VS. Delineating the pathway of cell-to-cell spread of
HIV-1 and the immunological consequences thereof may identify
novel targets for rational drug-design that can specifically inhibit
this mode of HIV-1 egress and limit HIV-1 pathogenesis.
Materials and Methods
Cells and viruses
Peripheral blood mononuclear cells were separated by density
gradient centrifugation (Histopaque, Sigma) and CD4
+ T cells
were purified by negative magnetic selection (Miltenyi Biotech).
Two clonal IL-2 dependent CD4
+ T cell lines derived from a
patient with Chediak-Higashi Syndrome were generously provid-
ed by Prof. G. Griffiths (The University of Cambridge, United
Kingdom) [34]. Dr Alain Fischer and Dr Genevieve de Saint
Basile (Hopital Necker Enfants Malades and INSERM Paris) also
kindly provided PBMCs from second CHS patient from which we
purified CD4
+ T cell PHA blasts after in vitro stimulation with
1 mg/ml PHA (Sigma) and 10 IU/ml IL-2 (Center for AIDS
Reagents [CFAR], National Institute for Biological Standards and
Control [NIBSC], UK). When initially isolating CD4
+ T cells from
CHS patient PBMCs, WT PBMCs were obtained from the
peripheral blood normal healthy donors by gradient centrifugation
of buffy coats (Brentwood Blood Center, National Health Service,
UK), cultured in parallel with CHS cells and CD4
+ T cells were
simultaneously purified. Control CD4
+ T cells used were either
CD4
+ T cell clones or CD4
+ T PHA blasts purified from activated
PBMCs obtained from at least four normal healthy donors.
Primary cells were maintained in RPMI 1640 (Invitrogen) con-
taining 5% human serum, 0.75% sodium bicarbonate (Invitrogen),
1 mM sodium pyruvate (Invitrogen), 2 mM L-glutamine (Invitro-
gen), 50 mM mercaptoethanol (Sigma) and 10 IU/ml IL-2. To
allow direct comparison in infection studies all CHS and control
CD4
+ T cells were maintained in vitro by synchronous restimula-
tion every 21 days with irradiated allogeneic peripheral blood
mononuclear cells and 1 mg/ml PHA. Cells were also cryogeni-
cally preserved for long-term storage to limit repeated stimula-
tions. The CD4
+/CXCR4
+ T cell line Jurkat CE6.1 (American
Type Culture Collection) and the derivative Jurkat line 1G5
containing the firefly luciferase gene driven by the HIV-1 LTR
(obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH: from Dr. Estuardo
Aguilar-Cordova and Dr. John Belmont)[43] were maintained in
RPMI 1640 supplemented with streptomycin (100 mg/ml),
penicillin (100 U/ml) and 10% fetal calf serum (FCS, Invitrogen).
For infection of primary cells with HIV-1, surface expression of
CD4, CXCR4 and CCR5 was measured by flow cytometry and
cells infected with either the CXCR4-tropic strain IIIB or the
CCR5-tropic strain BaL as described [7]. Jurkat cells were infected
with CXCR4-tropic strain IIIB. HIV-1 infected cells were
phenotyped as described [7].
Lentiviral shRNA knockdown in Jurkat T cells
Jurkat CE6.1 cells were infected with a MissionH shRNA len-
tiviral transduction particle set targeting Lyst (clones NM_000081.1-
3696s1c1, NM_000081.1-10178s1c1, NM_000081.1-493s1c1, NM_
000081.1-5055s1c1 and NM_000081.1-2538s1c1), syntaxin 4 (NM_
004604.3-574s1c1, NM_004604.3-360s1c1, NM_004604.3-646s1c1,
NM_004604.3-855s1c1, NM_004604.3-881s1c1) or lentivirus en-
coding a scrambled shRNA control (clone SHC002V) according to
manufacturer’s instructions (Sigma). Stable, lentivirus infected cells
(designated Lyst-shRNA, syntaxin 4-shRNA and control-shRNA)
were selected with puromycin (Sigma) and maintained inRPMI 1640
supplemented with 10% FCS, streptomycin (100 mg/ml), penicillin
(100 U/ml) and puromycin. Lyst mRNA levels were quantified with
reference to GAPDH using an Applied Biosystems 7500 Fast Real-
Time PCR System and Quantitect Primer and Sybr Green Probe
Assay kits (Qiagen). Syntaxin 4 knockdown was quantified by
Western blotting of cell lysates prepared from untreated Jurkat cells
and shRNA expressing cells using a mAb against sytaxin 4 (clone 49,




+ T cells were washed in cold fluorescence-activated cell
sorter (FACS) wash buffer (FWB: PBS with 1% FCS and 0.01%
sodium azide) and incubated for an hour on ice with mAbs against
CD4 (clone Q4120, donated by Q Sattentau and obtained from
the CFAR), CXCR4 (clone 12G5, donated by J Hoxie and
obtained from the CFAR), CCR5 (clone 2D7, obtained through
the AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH) or HIV-1 Env (IgG1b12, donated by D.
Burton and P Parren and obtained from the CFAR; 2G12 from
Polymun, Vienna). Cells were washed and incubated with anti-
mouse or anti-human IgG-phycoerythrin for 30 min on ice, fixed
with 1% formaldehyde and analyzed using a Becton Dickinson
FACS Calibur and CellQuest Software. Intracellular Gag staining
was performed by fixing cells, permeabilizing in perm/wash buffer
(BD Biosciences) and incubating with the Gag-specific mAb
KC57-PE (Beckman Coulter). For degranulation assays with
uninfected T cells, CD4
+ T cells were either left untreated or
incubated with 50 ng/ml PHA (Sigma) and 1 mg/ml ionomycin
(Sigma) for up to 1 h at 37uC in the presence of antibody against
CTLA-4 (mAb BNI3, BD Biosciences) or CD63 (a gift from G.
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oma Cell Bank, University of Iowa). Cells were washed, stained
with PE-conjugated anti-mouse secondary antibody and analyzed
by flow cytometry.
Immunofluorescence laser scanning confocal microscopy
CD4
+ T cells were washed in RPMI 1640-1% FCS (WB) and
incubated on poly-L-lysine (Sigma)-treated coverslips at 37uC for
30–60 minutes. In some cases, T cells were first activated on
immobilized anti-CD3 (1/1000 UCHT1 and 10 mg/ml OKT3)
for 24 hr, detached with cold PBS-5 mM EDTA, washed
extensively and resuspended in WB. Coverslip-adhered cells were
fixed in 4% formaldehyde for 15 minutes, permeabilized in 0.1%
Triton X-100-5% FCS or cold 100% methanol and washed
extensively in PBS-1% BSA. Immunostaining was performed with
the following antibodies: CTLA-4 was detected with the mouse
mAb BNI3 (IgG2a, BD Biosciences); FasL with NOK-1 (IgG1,B D
Biosciences); cathepsin D with polyclonal rabbit antibody
(Upstate); CD63 with mAb IB5 (IgG2b provided by M.Marsh,
University College London, UK); mitochondrial protein ATP
synthase subunit b with mAb 3D5 (IgG1, Abcam. A gift from M.
Duchen, University College London); HIV-1 Env with the human
mAb 2G12 (Polymun Scientific) or 50–69 (donated by S. Zoller-
Pasner and obtained from the CFAR) and HIV-1 Gag with rabbit
antisera against p17 and p24 (donated by G. Reid and obtained
from the CFAR) or the mouse mAb clone EH12E1 (donated by R.
Ferns and obtained from the CFAR). Primary antibodies were
detected with anti-human or anti-rabbit FITC, TRITC or Cy5-
conjugated secondary antibodies (Jackson Immunoresearch) and
isotype-specific anti-mouse Alexa-488, Alexa-568 and Alexa-647
(Invitrogen). Coverslips were mounted with ProLong antifade
(Invitrogen) and images were acquired using either a BioRad
Radiance 2000 MP or a Leica TCP SP2 laser scanning confocal
microscope with excitation wavelengths of 488, 568 or 633 nm
using 63x and 40x oil immersion objectives (NA 1.4). Image
processing was performed using Metamorph v.7 (Molecular
Devices) and Photoshop v.9 (Adobe). Colocalization was quanti-
fied using Metamorph, single xy slices were extracted from the
middle section of multiple cells (.20 per staining), thresholded and
correlation plots were generated to determine the Pearson’s
correlation coefficient (r).
To visualize endocytosed HIV-1 Env in CHS and WT cells, T
cells were infected with either BaL or NL43 at an MOI of 0.01 for
4 days, washed and incubated in fresh media supplemented with
10 mg/ml of the CD4 binding-site specific anti-Env mAb IgG1b12
for 24 h at 37uC. Cells were washed, fixed, permeabilized, and
stained with anti-CD63 or anti-CTLA4 primary antibodies
followed by anti-human secondary antibody (to detect IgGb12)
and anti-mouse isotype specific secondary antibodies (to detect
CD63 and CTLA-4) and examined by LSCM.
For conjugate and synapse experiments HIV-1 infected CHS or
WT CD4
+ T cells were mixed with autologous uninfected CD4
+ T
cells and incubated on coverslips in the presence of the non-
blocking HIV-1 Env mAb 50–69 for up to 2 h at 37uCa s
described previously [2]. Conjugates were then fixed, permeabi-
lized and stained for HIV-1 Gag or SL-associated proteins as
described above. Alternatively, HIV-1 infected T cells were mixed
with autologous target T cells prestained with the anti-CD4 mAb
L120 (donated by D Healey and obtained from the CFAR) and
incubated for 1 h at 37uC before being fixed, permeabilized and
stained for c-tubulin (Sigma) and HIV-1 Env with the mAb 2G12.
Primary antibodies were detected with species and isotype-specfic
antibodies and analyzed by LSCM as described above. For
quantification conjugates were defined as two closely apposed cells
consisting of one CD4
+ target cells and one HIV-1 infected cell
(Env
+ or Gag
+), a VS was defined as a conjugate showing
enrichment of viral proteins to sites of cell-cell contact.
Electron microscopy and tomography
HIV-1 infected Jurkat T cells were mixed with target CD4
+ T
cells and prepared for electron microscopy as described previously
[2]. 70 nm and 300 nm serial sections were obtained with a Leica
Ultracut UCT microtome and a diamond knife. Cell morphology
was assessed and quantified in 70 nm sections of two independent
samples and on two grids per sample in a systematic random
manner with a Philips Morgnani 268 TEM (100 kV). 2D images
were taken with a CCD camera on the same TEM. Tomography
was carried out essentially as described elsewhere [84]. Single or
dual axis digital image series from 300 nm sections were recorded
on a TECNAI microscope operated at 300 kV (4k FEI Eagle
camera at a pixel size of 1.99 nm, 2.54 nm or 4.96 nm on the
specimen level) over a 260u to 60u tilt range (increment 1u) and at
a defocus of 20.2 mm. Tomograms were reconstructed and joined
using the IMOD software package (version 4.1.4)[85]. The
AMIRA Visualization Package (version 5.2.0 Visage Imaging,
Berlin, Germany) was used for 3D image segmentation of the 2x
binned volumes by manually masking areas of interest, mask
thresholding and label smoothing. The volumes were Gauss
filtered (26262 kernel) for presentation in Videos S1–S4.
Quantification of HIV-1 replication in CHS and WT CD4
+ T
cells
For infection studies up to 5610
6 CHS cells and WT cells were
infected in parallel with the HIV-1 strain BaL or IIIB at an MOI
of 0.005. To quantify HIV-1 production in cultures infected with
replication competent virus (BaL or IIIB), cell-free supernatants
were collected from infected cells on days 4, 7 9 and 12 post-
infection and HIV-1 release was quantified by Gag p24 ELISA
[7]. Viral infectivity of cell-free supernatants was measured on
HeLa Tzm-bl reporter cells (donated by J. Kappes, X. Wu and
Tranzyme Inc. and obtained from the Center for AIDS Reagents,
National Institutes of Biological Standard and Control, UK) using
the Bright-Glo Luciferase assay kit (Promega). Viral infectivity was
normalized to Gag p24 to calculate the TCID50/ng p24 to
account for variation on HIV-1 release. To examine HIV-1 Env
incorporation into budding virions, virus was purified from cell-
free supernatants harvested from infected CHS and WT cultures
by ultracentrifugation through a 25% sucrose cushion, resus-
pended in PBS and stored at 280uC. Equal volumes of virus in
sample buffer were separated by SDS-PAGE on a 4–12% Bis-Tris
gradient gel (Invitrogen), transferred to nitrocellulose for Western
blotting and probed with rabbit antiserum raised against HIV-1
gp120 (donated by S.Ranjbar and obtained from the CFAR) and
HIV-1 Gag (donated by G. Reid and obtained from the CFAR)
followed by goat anti-rabbit-HRP and visualized by enhanced
chemiluminescence (ECL) (Amersham).
Single cycle virus release assay
293T cells were co-transfected with the VSV-G expressing
plasmid pMDG [86] and the Env- plasmid pNL4-3Luc.R.E
(obtained through the NIH AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH: from Dr.
Nathaniel Landau)[87] using PEI (Sigma) and VSV-G pseudo-
typed, replication-defective HIV-1 was harvested after 48 h and
quantified on HeLa Tzm-bl cells and by p24 ELISA. For single-
cycle virus release assays 1610
6 WT or CHS CD4
+ T cells were
infected with 100 ng pseudovirus for 16 h, washed to remove
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supernatants containing Gag p24 from the single-cycle infection
were harvested and the cell pellets were lysed with RIPA buffer
(radioimmunoprecipitation buffer: 50 mM Tris-HCl [pH 8],
150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% deoxycholic acid,
1 mM phenylmethlysulfonyl fluoride [PMSF], and Complete
protease inhibitor cocktail [Roche, UK]) on ice for 10 min and
soluble protein was collected by centrifugation at 15,0006 g for
10 min at 4uC. Protein concentrations were determined using the
BCA Protein Assay Reagent Kit (Pierce). Twenty micrograms of
cell lysate and an equal volume of virus in sample buffer were
separated by 10% SDS-PAGE, transferred to nitrocellulose for
Western blotting and probed with rabbit antiserum raised against
HIV-1 Gag and anti-actin (Sigma) followed by goat anti-rabbit-
HRP and visualized by ECL.
Quantification of HIV-1 entry into WT and CHS cells
1610
6 CD4
+ primary T cells were infected with the VSV-G
pseudotyped pNL4-3 Luc.R-E- virus at an MOI of 0.01 for 4 h,
excess virus was removed by washing and cells were incubated in
media for 24 h at 37uC. The cells were subsequently lysed and
infection was quantified by measuring luminescence using the
Bright-Glo luciferase assay (Promega).
Quantification of HIV-1 T cell-T cell spread
5610
5 Lyst-shRNA, syntaxin 4-shRNA or control-shRNA cells
chronically infected with HIV-1 IIIB at an MOI of 0.005 (10 days
post-infection) were mixed with an equal number of uninfected T
cells for up to 6 hours at 37uC, pelleted by centrifugation and the
genomic DNA extracted. Quantitative real-time PCR was
performed using an ABI 7000 to detect HIV-1 reverse transcripts
as a measure of cell-to-cell spread as described previously [7,45].
The HIV-1 pol copy number was normalized to the albumin or b-
globin housekeeping gene and the baseline signal at time point 0 h
was subtracted to account for the starting level of infection.
Alternatively, Lyst-shRNA, syntaxin 4-shRNA or control-shRNA
cells were infected with the HIV-1 strain IIIB at an MOI of 0.01,
incubated for 3 days and 1610
5 cells donor cells were mixed with
an equal number of 1G5 Jurkat T cells and incubated for 24 h at
37uC. 1G5 target cells were either left untreated or pretreated for
1 h at 37uC with the reverse transcriptase inhibitor Zidovudine to
achieve a final concentration of 50 mM (obtained from the NIH
AIDS Research and Reference Reagent Program) prior to mixing
with donor cells. After 24 h the cells were washed, lysed and
luciferase activity was measured by luminescence using the Bright-
Glo luciferase assay. To quantify the percentage of HIV-1 infected
donor cells 2610
5 cells were fixed in 4% formaldehyde, washed,
permeabilized and stained with the PE-conjugated HIV-1 Gag
specific antibody and analyzed by flow cytometry using a
FACSCalibur. The percentage of infected cells was quantified
with reference to uninfected Jurkat cells stained for Gag. To
quantify cell-to-cell spread with WT and CHS T cells, cells were
infected with the HIV-1 strain NL4-3 at an MOI of 0.01,
incubated for 48 h and 1610
5 cells donor cells were mixed in
triplicate with an equal number of 1G5 Jurkat T cells and
incubated for 24 h at 37uC. After 24 h the cells were washed, lysed
and luciferase activity was measured by luminescence using the
Bright-Glo luciferase assay.
Statistical analysis
Statistical significance was calculated either using the paramet-
ric Anova test for multiple comparisons with Bonferroni cor-
rection, or the non-parametric Mann-Whitney test. Significance
was assumed when p,0.05. Pearson’s correlation coefficients (r
values) were calculated using Metamorph.
Supporting Information
Figure S1 Unpolarized morphology of uninfected and
unconjugated T cells. Infected Jurkat T cells and primary
CD4
+ T cells were fixed and embedded. a) – c) 70nm thin sections
were post-stained with lead citrate and examined in the electron
microscope. a) Conjugate of two uninfected cells, both unpolar-
ized. b), c) single HIV-1 infected (b) and uninfected (c) cells, both
unpolarized as seen by the even distribution of cellular organelles
around the nucleus (outlined in red). d) – f) single computational
slices and 3D surface rendering of reconstructed tomograms from
300nm sections. Cells are unpolarised, as seen by the even
distribution of secretory organelles (endoplasmic reticulum, ER,
not pseudocolored), secretory lysosomes (SL, orange), Golgi (not
pseudocolored), mitochondria (m, green) and lipid bodies (LB, pale
blue) around the nucleus (brown). Arrows in b) and e) indicate
virus particles (red) released from infected cells (plasma membrane
depicted in red). Scale bars= 1 mm.
(TIF)
Figure S2 Localization of cellular proteins to secretory
lysosomes in CD4
+ T cells. A) CD4
+ T cells were purified from
healthy donors, activated, permeabilized and stained for CD63,
cathepsin D, CTLA-4 and FasL. Primary antibodies were detected
with fluorophore-conjugated anti-rabbit and isotype-specific anti-
mouse secondary antibodies. Images are 3D reconstructions of
serial z-sections taken by LSCM with the corresponding merged
and DIC images are shown. Scale bar = 5mm. B) Quantification
of colocalization (average r value) between cathepsin D and CD63
(n=31), cathepsin D and CTLA-4 (n=21), cathepsin D and FasL
(n=20), CD63 and CTLA-4 (n=20), and CD63 and FasL (n=20)
is shown. Quantification was performed using single xy slices.
Error bars are the SEM from four experiments performed using
six individual donors.
(TIF)
Figure S3 CD3 antibody is not internalized following T
cell activation. CD4
+ T cells were activated on plate-
immobilized anti-CD3, detached with EDTA, washed, permeabi-
lized and stained with isotype-specific anti-mouse IgG1 (top panel),
IgG2a (middle) and IgG2b (lower) secondary antibody and
analysed by LSCM. We did not detect intracellular CD3 staining,
confirming the specificity of the CD63, CTLA-4 and FasL
staining.
(TIF)
Figure S4 CHS CD4
+ T cells show a defect in degran-
ulation. Normal CD4
+ T cells (white bars) or CHS CD4
+ T cells
(black bars) were either untreated (UT) or stimulated with PMA-
ionomycin for 10 min or 60 min in the presence of mAbs specific
for CTLA-4 or CD63. Cells were washed, stained with anti-mouse
phycoerythrin-conjugated secondary antibody and surface expres-
sion of CTLA-4 (top panel) and CD63 (lower panel) was measured
by flow cytometry. Graphs show the MFI and SEM of data
combined from four experiments performed with four indepen-
dent WT donors and two different CHS clones.
(TIF)
Figure S5 Gag does not localize to SL-related compart-
ments in CHS CD4
+ T cells. HIV-1-infected CHS cells were
fixed, permeabilized and stained for Env (red), Gag (blue) and
CD63 (green). Images are 3D reconstructed z-series and areas of
colocalization are yellow.
(TIF)
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cells. A) Total cellular RNA was extracted from Jurkat T cells
stably expressing scrambled shRNA sequences (control cells, white
bars) or Lyst-specific shRNA (black bars) and the relative
quantification of Lyst mRNA determined by real-time reverse
transcription PCR. Data are expressed as relative mRNA levels
compared to control cells that are normalized to 1. Error bars
represent the SEM from multiple experiments. B) Cells expressing
scrambled shRNA (top panel) or Lyst-shRNA (bottom panel) were
fixed, permeabilized and stained for CD63 (green).
(TIF)
Figure S7 Quantification of syntaxin 4 knockdown in
Jurkat T cells. Total cell lysates were separated by SDS-PAGE
and Western blotting performed to determine the relative
expression of syntaxin 4 protein in control-shRNA expressing
cells, syntaxin 4-shRNA expressing cells and untreated Jurkat cells.
The relative quantification of sytaxin 4 levels determined by
densitometer analysis is shown.
(TIF)
Video S1 Polarization of HIV-1 infected T cells at the
virological synapse. Animation through a z-series of 3.99nm
thick digital slices of a dual axis tomogram, reconstructed from two
sequential 300nm thick sections of Jurkat cells mixed with
uninfected CD4
+ T cells. Colored overlay is a 3D surface model
of organelle redistribution towards the site of virus particle (red)
release in the infected cell. Plasma membranes (semi-transparent)
are depicted in red (infected cell) and yellow (uninfected cell) and
the nucleus in brown. Organelles are rendered as follows:
mitochondria (green), lipid bodies (pale blue), lysosomes (orange)
and microtubule organizing centre (blue).
(MOV)
Video S2 Uninfected T cells conjugates are non-polar-
ized. Animation through a z-series of 5nm thick digital slices of a
single axis 1x2 montage tomogram, reconstructed from a 300nm
thick section of Jurkat cells mixed with uninfected CD4
+ T cells.
Colored overlay is a 3D surface model of the unpolarized
morphology. Plasma membranes (semi-transparent) are depicted
in yellow and the nucleus in brown. Organelles are rendered as
follows: mitochondria (green), lipid bodies (pale blue) and
lysosomes (orange).
(MOV)
Video S3 Unconjugated, infected T cells are non-
polarized. Animation through a z-series of 5nm thick digital
slices of a single axis tomogram, reconstructed from a 300nm thick
section of a single, infected Jurkat T cell is shown. Colored overlay
is a 3D surface model of the unpolarized morphology. Plasma
membrane (semi-transparent) is depicted in red and the nucleus in
brown. Organelles are rendered as follows: mitochondria (green),
lipid bodies (pale blue) and lysosomes (orange). Virus is colored
red.
(MOV)
Video S4 Unconjugated, uninfected T cells are non-
polarized. Animation through a z-series of 2.5nm thick digital
slices of a single axis tomogram, reconstructed from a 300nm thick
section of a single, noninfected T cell is shown. Colored overlay is
a 3D surface model of the unpolarised morphology of the two
uninfected cells. Plasma membrane (semi-transparent) is depicted
in yellow and the nucleus in brown. Organelles are rendered as
follows: mitochondria (green), lysosomes (orange).
(MOV)
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